Essential thrombocytemia progressing to Ph+ chronic myeloid leukemia with megakaryoblastic blasts, following anagrelide withdrawal.

Andrea Piccin,Daisy Corvetta,Ugo Rovigatti,Guido Mazzoleni,Irene Pusceddu,Mirija Svaldi,Michael Steurer,Günther Gastl,Sergio Cortelazzo

Essential thrombocytemia progressing to Ph+ chronic myeloid leukemia with megakaryoblastic blasts, following anagrelide withdrawal.

2014

Andrea Piccin
Daisy Corvetta
Ugo Rovigatti
Guido Mazzoleni
Irene Pusceddu
Mirija Svaldi
Michael Steurer
Günther Gastl
Sergio Cortelazzo

To the editor,Anagrelide (ANA) is a drug currently prescribed to control platelet (PLT) count in patients with essential thrombocythemia (ET). Overall ANA action is confined to megakaryocytopoiesis...

Keywords:

Diabetes mellitus
Myeloid leukemia
Biochemistry
Hematology
Platelet aggregation inhibitor
Medicine
Cancer research
Essential thrombocythemia
Anagrelide
Megakaryocyte Progenitor Cells
Essential Thrombocytemia
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations